D-Wave Quantum stock slides after Quantum Circuits deal closes and a 10.4 million-share resale filing hits
21 January 2026
2 mins read

D-Wave Quantum stock slides after Quantum Circuits deal closes and a 10.4 million-share resale filing hits

NEW YORK, Jan 20, 2026, 20:14 EST — Market closed.

  • Shares of D-Wave Quantum slipped 6.2%, ending Tuesday at $27.04
  • A filing registered as many as 10.43 million shares for resale linked to the Quantum Circuits acquisition
  • Investors are on alert for selling pressure and new insights at D-Wave’s Qubits conference next week

D-Wave Quantum Inc. shares dropped 6.2% on Tuesday, ending the day at $27.04. The quantum computing firm completed its acquisition of Quantum Circuits and filed a resale registration that might increase shares available for trading. The stock fluctuated between $25.96 and $28.48, with roughly 51 million shares traded.

The company submitted a prospectus supplement dated Jan. 20, outlining the resale of up to 10,430,444 shares by selling stockholders. It clarified that the company itself will not gain any proceeds from these sales. The filing also noted that the selling stockholders may sell “any, all or none” of the shares, leaving investors uncertain about how quickly these shares could hit the market. 1

In a separate filing, D-Wave confirmed it closed the Quantum Circuits deal on Jan. 20, shelling out $250 million in cash plus 10,430,444 shares of common stock, pending adjustments. At Tuesday’s close, those shares were valued at roughly $282 million, bringing the total upfront price to about $532 million before any tweaks. The company also warned of integration risks and noted its stock could drop if the anticipated benefits take longer to materialize. 2

Quantum computing stocks mostly slipped during the session. IonQ finished close to unchanged, but Rigetti Computing dropped roughly 2%, and Quantum Computing Inc fell nearly 6%, highlighting the sector’s volatile moves.

The deal brings a gate-model quantum program onto D-Wave’s existing “annealing” platform. Unlike annealing machines, which focus on optimization tasks like scheduling and routing, gate-model systems are designed to execute a broader range of algorithms through sequences of quantum operations.

D-Wave said Quantum Circuits brings error-corrected superconducting gate-model technology and a “dual-rail” qubit approach designed to simplify error correction. CEO Alan Baratz called the acquisition a “watershed moment.” Rob Schoelkopf, co-founder of Quantum Circuits and now D-Wave’s chief scientist, said the deal gives the company “a decisive advantage” in gate-model quantum computing. D-Wave plans to launch its first gate-model system in 2026 and highlighted its Qubits 2026 conference, set for Jan. 27-28 in Boca Raton, Florida. 3

Per the registration rights agreement signed at closing, D-Wave must file a shelf registration statement—or a prospectus supplement to an existing shelf—within three business days. However, the company can delay if trading blackout periods apply or if filing would reveal material nonpublic information. 4

QBTS holders face a near-term risk as the market shifts attention away from the technology story and zeroes in on the mechanics: integration expenses, cash burn following a $250 million cash payout, and the potential rush by ex-Quantum Circuits shareholders to offload registered shares amid volatile trading.

U.S. trading picks up again Wednesday, with investors eyeing potential selling linked to the newly registered shares and any fresh updates on the gate-model roadmap timeline. The next big date on the calendar is the Qubits 2026 event, slated for Jan. 27-28.

Stock Market Today

Sungrow Power Supply (300274.SZ) A-shares: Monday watch after “commercial space” denial

Sungrow Power Supply (300274.SZ) A-shares: Monday watch after “commercial space” denial

8 February 2026
Sungrow closed at 144.50 yuan, down 1.03%, after stating it has no plans in the commercial space sector. Mainland China trading resumes Monday, with Spring Festival closures set for Feb. 15–23. Major funds were net sellers of 5.46 billion yuan on Feb. 6. The Shenzhen-listed solar firm remains under scrutiny as investors await further filings before the holiday.
MPWR stock price hits a new high after Monolithic Power’s outlook — what traders watch next week

MPWR stock price hits a new high after Monolithic Power’s outlook — what traders watch next week

8 February 2026
Monolithic Power Systems shares surged 6.4% to $1,229.82 Friday, hitting a new 52-week high after raising its dividend to $2.00 and forecasting first-quarter revenue of $770 million to $790 million. CEO Michael Hsing filed a Rule 144 notice for 3,082 shares. CFO Bernie Blegen will retire after the 2025 annual report, with Rob Dean named interim CFO. Fourth-quarter revenue rose 20.8% to $751.2 million.
Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls

Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls

8 February 2026
Microchip Technology shares fell 2.6% to $76.01 Friday after its outlook and analyst reactions disappointed some investors. The company reported fiscal Q3 net sales up 15.6% to $1.186 billion and guided March-quarter sales to $1.24–$1.28 billion. A global memory shortage has disrupted orders, and analysts remain split on recovery prospects. BlackRock disclosed a 10% stake as of Jan. 31.
Renesas stock price jumps again as $3 billion SiTime deal keeps traders hooked on 6723

Renesas stock price jumps again as $3 billion SiTime deal keeps traders hooked on 6723

8 February 2026
Renesas shares closed at 2,957.5 yen on Friday, up 6.9% after announcing a $3 billion cash-and-stock deal to transfer its timing business to SiTime, with closing targeted by end-2026. Renesas forecast March-quarter revenue of 367.5–382.5 billion yen and a 58.5% gross margin. The company reported 2025 revenue of 1.32 trillion yen and a non-GAAP profit of 329.3 billion yen.
ImmunityBio (IBRX) stock jumps on FDA’s 30-day ANKTIVA resubmission path — what’s next
Previous Story

ImmunityBio (IBRX) stock jumps on FDA’s 30-day ANKTIVA resubmission path — what’s next

Chevron stock price slips as Tengiz shutdown headlines hit CVX; Turkey talks add fresh focus
Next Story

Chevron stock price slips as Tengiz shutdown headlines hit CVX; Turkey talks add fresh focus

Go toTop